Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 29:7:1480-1486.
doi: 10.1016/j.toxrep.2020.10.017. eCollection 2020.

Impact of switching to a heat-not-burn tobacco product on CYP1A2 activity

Affiliations

Impact of switching to a heat-not-burn tobacco product on CYP1A2 activity

Angela van der Plas et al. Toxicol Rep. .

Erratum in

Abstract

Background: Cigarette smoking induces cytochrome P450 1A2 (CYP1A2) expression and activity, while smoking cessation normalizes the levels of this enzyme. The aim of this publication is to summarize the data on CYP1A2 gene expression and activity in preclinical and clinical studies on the Tobacco Heating System (THS), currently marketed as IQOS® with HEETs®, and to summarize the potential effects on CYP1A2 to be expected upon switching to reduced-risk products (RRPs).

Methods: We summarized PMI's preclinical and clinical data on the effects of switching from cigarette smoking to THS.

Results: Data from four preclinical mouse and rat studies showed that, upon either cessation of cigarette smoke exposure or switching to THS exposure, the upregulation of CYP1A2 observed with exposure to cigarette smoke reverted close to fresh-air levels. Data from four clinical studies yielded similar results on CYP1A2 activity within a time frame of five days. Furthermore, the effects of switching to THS were similar to those seen after smoking cessation.

Conclusions: Because smoking cessation and switching to either electronic cigarettes or THS seem to have similar effects on CYP1A2 activity, the same measures taken for patients treated with narrow therapeutic index drugs that are metabolized by CYP1A2 and who quit smoking should be recommended for those switching to RRPs.

Keywords: CYP1A2; Narrow therapeutic drugs; Tobacco Heating System (THS).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Siest G., Jeannesson E., Marteau J.B., Samara A., Marie B., Pfister M. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab. Dispos. 2008;36(1):182–189. doi: 10.1124/dmd.107.017228. PubMed PMID: 17940135. - DOI - PubMed
    1. Anderson G.D., Chan L.N. Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products. Clin. Pharmacokinet. 2016;55(11):1353–1368. doi: 10.1007/s40262-016-0400-9. PubMed PMID: 27106177. - DOI - PubMed
    1. Gabriel L., Tod M., Goutelle S. Quantitative prediction of drug interactions caused by CYP1A2 inhibitors and inducers. Clin. Pharmacokinet. 2016;55(8):977–990. doi: 10.1007/s40262-016-0371-x. PubMed PMID: 26936044. - DOI - PubMed
    1. Ding X., Kaminsky L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 2003;43:149–173. doi: 10.1146/annurev.pharmtox.43.100901.140251. PubMed PMID: 12171978. - DOI - PubMed
    1. Pelkonen O., Maenpaa J., Taavitsainen P., Rautio A., Raunio H. Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica. 1998;28(12):1203–1253. doi: 10.1080/004982598238886. PubMed PMID: 9890159. - DOI - PubMed

LinkOut - more resources